Home
User Profile
  • 2010-2017 Successive Undergraduate and Postgraduate Program, Master’s Degree in Clinical Medicine, The Second Affiliated Hospital, School of Medicine, Zhejiang University, P.R. China
  • 2017-Present Ph.D. Candidate in Orthopedic Surgery, The Second Affiliated Hospital, School of Medicine, Zhejiang University, P.R. China
  • 2018-Present Research Fellow, Massachusetts General Hospital, Boston, MA
  • (1) Wang SD, Li HY, Ye CY, Lin P, Li BH, Zhang W, Sun LL, Wang Z, Xue DT, Teng WSY, Zhou XZ, Lin N, Ye ZM. Valproic acid combined with zoledronate enhance γδ T cell-mediated cytotoxicity against osteosarcoma cells via the accumulation of mevalonate pathway intermediates. Front Immunol 2018, doi: 10.3389/fimmu.2018;9:377
  • (2) Wang SD, Li HY, Li BH, Xie T, Zhu T, Sun LL, Ren HY, Ye ZM. The role of CTLA-4 and PD-1 in anti-tumor immune response and their potential efficacy against osteosarcoma. INT IMMUNOPHARMACOL 2016;38:81
  • Application of existing FDA approved molecules to favorably modulate intratumoral immune function